NASDAQ:AMAG
Delisted
AMAG Pharmaceuticals Stock News
$13.75
+0 (+0%)
At Close: May 27, 2022
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More
12:55pm, Friday, 01'st May 2020
Remdesivir, the investigational Gilead Sciences antiviral drug, looks more likely than ever to become the first treatment authorized by the FDA to treat
Goldfinch Bio Expands Executive Leadership Team
12:00pm, Thursday, 30'th Apr 2020
Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney disease, today announced the appointment of Kyle
H.C. Wainwright Reaffirms Their Buy Rating on Amag Pharmaceuticals (AMAG)
11:19am, Wednesday, 29'th Apr 2020
In a report released today,
Douglas Tsao
from H.C. Wainwright maintained a
Buy
rating on Amag Pharmaceuticals (
AMAG
–
Research Report
), with a price target of
$9.00
. The company’s shares closed
Amag Pharma Appoints Rainier's Myers to Succeed CEO William Heiden
12:25am, Wednesday, 29'th Apr 2020
AMAG Pharmaceuticals (NASDAQ: ]) on Tuesday announced Scott Myers has been appointed its new CEO. Myers was most recently CEO of bladder cancer drug
AMAG Pharmaceuticals (AMAG) Earnings Expected to Grow: What to Know Ahead of Q1 Release
04:33pm, Tuesday, 28'th Apr 2020
AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMAG Pharmaceuticals (AMAG) Earnings Expected to Grow: What to Know Ahead of Q1 Release
04:33pm, Tuesday, 28'th Apr 2020
AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRIEF-AMAG Pharmaceuticals Appoints Scott Myers As President And Chief Executive Officer
11:48am, Tuesday, 28'th Apr 2020
AMAG Pharmaceuticals Inc:
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
11:00am, Tuesday, 28'th Apr 2020
AMAG Pharmaceuticals, Inc. (AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief Executive Officer, and member of the Board, effective immediatel
Analysts Anticipate AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) to Post $0.01 EPS
10:00am, Tuesday, 28'th Apr 2020
Equities research analysts expect AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) to post earnings per share of $0.01 for the current quarter, Zacks Investment Research reports. Six analysts have made estima
AMAG Pharmaceuticals (NASDAQ:AMAG) Upgraded to "Hold" by BidaskClub
08:54am, Tuesday, 28'th Apr 2020
AMAG Pharmaceuticals (NASDAQ:AMAG) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, BidAskClub reports. Several other br
AMAG Pharma Reports Pres, CEO William Heiden To Step Down; Names Scott Myers Replacement
12:00am, Tuesday, 28'th Apr 2020AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020
08:30pm, Monday, 27'th Apr 2020
WALTHAM, Mass., April 27, 2020 -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2020 financial results will be released on Monday, May 11,.
Brokerages Anticipate AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Will Post Quarterly Sales of $65.28 Million
05:14am, Monday, 27'th Apr 2020
Equities research analysts predict that AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will report sales of $65.28 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts hav
Geode Capital Management LLC Increases Stake in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)
09:10am, Saturday, 25'th Apr 2020
Geode Capital Management LLC increased its holdings in shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with th
Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors
12:00pm, Tuesday, 21'st Apr 2020
NEW YORK and CLEVELAND, April 21, 2020 -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced appointments of Brian.